Bridging Global Disparities in Drug Allergy Through AI-Assisted Training for Non-Specialists: Findings From the Multinational ADAPT-2 Course.

ABSTRACT:

Background

Mislabelled drug allergy (DA) remains a global public health challenge. A prior randomised trial (ADAPT) demonstrated that an intensive educational course improved DA knowledge and confidence among non-specialists. However, ADAPT was restricted to English-speaking participants and its generalisability remains unknown. To address this, a multinational implementation study expanding ADAPT (ADAPT-2) was performed.

Methods

Non-allergist physicians from Colombo (Sri Lanka), Guangzhou and Shenzhen (Mainland China), Hong Kong (Special Administrative Region of China) and Perth (Australia) completed a standardised DA educational course. In Mainland China, training was delivered via AI-assisted video localisation (converted into Mandarin while preserving the speaker's voice

SUBMITTER: Mak HWF 

PROVIDER: S-EPMC12879266 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature